Products & Services

Adiposet

Require multiple general anaesthetic procedures;

Regenerys

Require multiple general anaesthetic procedures;

MySkin & CryoSkin

Require multiple general anaesthetic procedures;

Trauma reconstruction

Require multiple general anaesthetic procedures;

CRO & CRM services

Require multiple general anaesthetic procedures;

Adiposet

Require multiple general anaesthetic procedures;

Regenerys

Require multiple general anaesthetic procedures;

MySkin & CryoSkin

Require multiple general anaesthetic procedures;

Trauma reconstruction

Require multiple general anaesthetic procedures;

CRO & CRM services

Require multiple general anaesthetic procedures;

Stem Cells & Regenerative Medicine

Stem Cells certainly qualify as one of the emerging major discoveries of modern medicine.

Their role and function is rapidly being understood across all aspects of health and bodily function, and the manipulation and application of them holds out the prospect of major new therapies in the coming decades. Importantly, many of these new therapies will be in fields that are proving intractable to current medicinal and biotech approaches.

Examples include:

  • Eyes
  • Hair
  • Joints
  • Nerve repair
  • Heart tissue
  • Organ regeneration & damage repair
  • Clonal tissue
  • Specific, targeted or medicines
  • Skin rejuvenation

Major challenges are slowly being overcome, starting with sourcing adequate quantities of Stem-Cells from adults. Bone marrow and blood are proving to have associated issues, but fortunately the body also produces and stores large quantities of Stem-Cells in easily accessible adipose reserves.

T&CT has developed a deep pool of experience in handling, processing and effectively storing human tissue, and particularly adipose, over nearly 20 years. Significantly, we believe that our proprietary technology – fully FDA compliant – is currently among the the leaders in the industry in being able to guarantee high levels of cell survivability through cryo-preservation, storage and thaw up to 90-95% cell viability in the most cases.

T&CT partners with acknowledged leaders to provide our advanced tissue handling technology to the development of new procedures and therapies and will be at the forefront of Stem-cell based and autologous tissue therapies, particularly where long-term storage and recovery of tissue/product/sample is essential.